Tag: Cancer: Pancreatic
ASCO: Olaparib Beats Placebo for BRCA-Related Pancreatic Cancer
Progression-free survival significantly improved with olaparib versus placebo for metastatic disease
Cancer Consultation Low in Noncurable Pancreatic Adenocarcinoma
Likelihood of cancer-directed therapy higher for first consult with medical, radiation oncology versus surgery
Neoadjuvant Chemotherapy Key to Survival in Pancreatic Cancer
Three factors independently linked to prolonged survival in BR/LA pancreatic ductal adenocarcinoma
AACR: High BMI Before 50 Raising Pancreatic Cancer Mortality
Twenty-eight percent of pancreatic cancer deaths due to higher BMI in those born in 1970 to 1974
Tooth Loss May Up Pancreatic Cancer Risk in Black Women
Pancreatic cancer risk increased with tooth loss, especially loss of five or more teeth
USPSTF Still Recommends Against Pancreatic Cancer Screening
No evidence seen for benefits of pancreatic cancer screening, treatment of screen-detected cancer
Modified-FOLFIRINOX Beneficial in Resected Pancreatic Cancer
Disease-free, overall survival significantly longer compared with gemcitabine, but more adverse events
Obesity as a Teen Ups Risk for Later Pancreatic Cancer
In men, overweight and even higher normal weight tied to increased risk
Recent-Onset Diabetes Tied to Increased Pancreatic Cancer Risk
Latinos, African-Americans with recent-onset disease have higher risk than those with long-term disease
ASCO: mFOLFIRINOX Improves Survival in Pancreatic Cancer
And, pre-op chemoradiotherapy linked to longer overall survival than immediate surgery
